TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
Revenue
2
0
0
0
0
0
Revenue Growth (YoY)
100%
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
5
1
1
1
0
1
Research & Development
--
--
--
--
--
--
Operating Expenses
5
1
1
1
0
1
Other Non Operating Income (Expenses)
2
0
1
0
0
0
Pretax Income
0
0
0
0
0
0
Income Tax Expense
0
0
0
0
0
--
Net Income
0
0
0
0
0
0
Net Income Growth
-100%
--
-100%
--
--
-100%
Shares Outstanding (Diluted)
11.57
11.57
11.57
11.55
11.53
11.53
Shares Change (YoY)
0%
0%
0%
0%
4%
8%
EPS (Diluted)
0
0
0.04
-0.05
0
-0.04
EPS Growth
-102%
-109%
-152%
-22%
-113.99%
-84%
Free Cash Flow
2
1
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
-100%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
100%
0%
0%
0%
0%
0%
EBITDA
-2
0
0
0
0
0
EBITDA Margin
-100%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-2
0
0
0
0
0
EBIT Margin
-100%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
--
Follow-Up Questions
What are TherapeuticsMD Inc's key financial statements?
According to the latest financial statement (Form-10K), TherapeuticsMD Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for TXMD?
TherapeuticsMD Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is TherapeuticsMD Inc's revenue broken down by segment or geography?
TherapeuticsMD Inc largest revenue segment is License, at a revenue of 1,302,000 in the most earnings release.For geography, United States is the primary market for TherapeuticsMD Inc, at a revenue of 1,302,000.
Is TherapeuticsMD Inc profitable?
no, according to the latest financial statements, TherapeuticsMD Inc has a net loss of $0
Does TherapeuticsMD Inc have any liabilities?
no, TherapeuticsMD Inc has liability of 0
How many outstanding shares for TherapeuticsMD Inc?
TherapeuticsMD Inc has a total outstanding shares of 0